NKTX news

Latest 2 stories · newest Nov 6, 2026

NKTX
Nkarta Announces Clinical Data Webcast for NKX019 in Autoimmunity

Nkarta will host a webcast to review initial clinical data for NKX019 at ACR Convergence 2026. The presentation highlights the Ntrust program's approach to resetting the immune system in autoimmune diseases like myositis and systemic sclerosis.

NKTX
NKTX reports third quarter financial results and clinical updates

Nkarta Inc. reported a third-quarter 2026 net loss of $33.3 million and announced plans to present initial clinical data for NKX019 at upcoming conferences, forecasting current cash to fund operations until 2029.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same NKTX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/NKTX/newsSTART FREE